Early goal-directed therapy in severe sepsis and septic shock revisited: concepts, controversies, and contemporary findings.
暂无分享,去创建一个
David T. Huang | S. Trzeciak | T. Osborn | M. Goyal | D. Gaieski | H. Nguyen | E. Rivers | R. Otero | K. Gunnerson | R. Sherwin | C. Holthaus | H. Nguyen
[1] Scott T. Micek,et al. Before–after study of a standardized hospital order set for the management of septic shock* , 2006, Critical care medicine.
[2] G. Bernard,et al. Comparison of two fluid-management strategies in acute lung injury. , 2006, The New England journal of medicine.
[3] S. Magder. Central venous pressure: A useful but not so simple measurement , 2006, Critical care medicine.
[4] A. Kelly,et al. Agreement between arterial and central venous values for pH, bicarbonate, base excess, and lactate , 2006, Emergency Medicine Journal.
[5] E. Ruokonen,et al. Mixed venous oxygen saturation cannot be estimated by central venous oxygen saturation in septic shock , 2006, Intensive Care Medicine.
[6] E. Rivers. Fluid-management strategies in acute lung injury--liberal, conservative, or both? , 2006, The New England journal of medicine.
[7] K. Wood,et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock* , 2006, Critical care medicine.
[8] S. Lobo,et al. Prospective, randomized trial comparing fluids and dobutamine optimization of oxygen delivery in high-risk surgical patients [ISRCTN42445141] , 2006, Critical care.
[9] S. Trzeciak. Operationalizing the Use of Serum Lactate Measurement for Identifying High Risk of Death in a Clinical Practice Algorithm for Suspected Severe Sepsis , 2006 .
[10] A. J. Garcia. Point-of-care Lactate Testing as a Predictor of Mortality in a Heterogeneous Emergency Department Population , 2006 .
[11] M. Bauer,et al. Implementation of an evidence-based “standard operating procedure” and outcome in septic shock* , 2006, Critical care medicine.
[12] Daniel Talmor,et al. Implementation and outcomes of the Multiple Urgent Sepsis Therapies (MUST) protocol* , 2006, Critical care medicine.
[13] M. Sartzi,et al. First-aid treatment of hydrofluoric acid skin burns with 2.5% calcium gluconate gel: an experimental controlled study , 2006, Critical Care.
[14] E. Ferlin,et al. Influence of the blood on the time course of pancreatitis-induced lung injury evaluated in isolated blood-perfused rat lungs , 2006, Blood Purification.
[15] R. Berry,et al. Improvement in Stroke Mortality in Canada and the United States, 1990 to 2002 , 2006, Circulation.
[16] Didier Payen,et al. Does dopamine administration in shock influence outcome? Results of the Sepsis Occurrence in Acutely Ill Patients (SOAP) Study* , 2006, Critical care medicine.
[17] E. Rivers. Mixed vs central venous oxygen saturation may be not numerically equal, but both are still clinically useful. , 2006, Chest.
[18] J. Parrillo,et al. Translating research to clinical practice: a 1-year experience with implementing early goal-directed therapy for septic shock in the emergency department. , 2006, Chest.
[19] H. Rogove,et al. COLLABORATION FOR INSTITUTING THE SURVIVING SEPSIS CAMPAIGN IN A COMMUNITY HOSPITAL.: 110-S , 2005 .
[20] F. Gao,et al. The impact of compliance with 6-hour and 24-hour sepsis bundles on hospital mortality in patients with severe sepsis: a prospective observational study , 2005, Critical care.
[21] Robert W. Armstrong,et al. Results of Implementing a Rapid Response Team Approach in Treatment of Shock in a Community Hospital , 2005 .
[22] A. Coquerel,et al. Serum Erythropoietin Levels in Septic Shock , 2005, Anaesthesia and intensive care.
[23] S. Lowry,et al. THE SAFETY OF DROTRECOGIN ALFA (ACTIVATED): INDEPTH DATA ANALYSIS SUGGESTS SURVIVAL BENEFIT INDEPENDENT OF SERIOUS ADVERSE EVENT OCCURRENCES , 2005 .
[24] James A Russell,et al. Early changes in organ function predict eventual survival in severe sepsis* , 2005, Critical care medicine.
[25] A. Verceles,et al. S.E.P.S.I.S: SEPSIS EDUCATION PLUS SUCCESSFUL IMPLEMENTATION AND SUSTAINABILITY IN THE ABSENCE OF A RAPID RESPONSE TEAM , 2005 .
[26] R. Rossaint,et al. Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death. , 2005, The New England journal of medicine.
[27] T. Osborn,et al. Emergency medicine and the surviving sepsis campaign: an international approach to managing severe sepsis and septic shock. , 2005, Annals of emergency medicine.
[28] H. Nguyen,et al. Improving the Uniformity of Care with a Sepsis Bundle in the Emergency Department , 2005 .
[29] M. Goyal,et al. Mortality Benefit After Implementation of Early Goal Directed Therapy Protocol for the Treatment of Severe Sepsis and Septic Shock , 2005 .
[30] S. Trzeciak,et al. Clinical manifestations of disordered microcirculatory perfusion in severe sepsis , 2005, Critical care.
[31] J. Kline,et al. Use of goal-directed therapy for severe sepsis and septic shock in academic emergency departments. , 2005, Critical care medicine.
[32] J. Ioannidis. Contradicted and initially stronger effects in highly cited clinical research. , 2005, JAMA.
[33] V. Pettilä,et al. Hemodynamic variables related to outcome in septic shock , 2005, Intensive Care Medicine.
[34] M. Donnino. B-type Natriuretic Peptide in Severe Sepsis and Septic Shock , 2005 .
[35] F. Sebat,et al. A multidisciplinary community hospital program for early and rapid resuscitation of shock in nontrauma patients. , 2005, Chest.
[36] Larry A Nathanson,et al. Serum lactate as a predictor of mortality in emergency department patients with infection. , 2005, Annals of emergency medicine.
[37] Milo Engoren,et al. The effect of prompt physician visits on intensive care unit mortality and cost , 2005, Critical care medicine.
[38] C. Silliman,et al. Transfusion-related acute lung injury. , 2005, Blood.
[39] Arnaldo Dubin,et al. Shock on admission day is the best predictor of prolonged mechanical ventilation in the ICU. , 2005, Chest.
[40] M. Donnino,et al. SURROGATE MARKERS FOR LACTIC ACIDOSIS IN PATIENTS WITH SEVERE SEPSIS AND SEPTIC SHOCK: 542 , 2004 .
[41] L. Chawla,et al. Lack of equivalence between central and mixed venous oxygen saturation. , 2004, Chest.
[42] A. Wolff,et al. Using checklists and reminders in clinical pathways to improve hospital inpatient care , 2004, The Medical journal of Australia.
[43] D. Annane,et al. Practice parameters for hemodynamic support of sepsis in adult patients: 2004 update , 2004, Critical care medicine.
[44] R. Pino,et al. Utility of B-type natriuretic peptide for the evaluation of intensive care unit shock* , 2004, Critical care medicine.
[45] G. Jacobsen,et al. Early lactate clearance is associated with improved outcome in severe sepsis and septic shock* , 2004, Critical care medicine.
[46] C. Hartog,et al. Continuous central venous and pulmonary artery oxygen saturation monitoring in the critically ill , 2004, Intensive Care Medicine.
[47] S. Finfer,et al. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. , 2004, The New England journal of medicine.
[48] J. Bartlett,et al. Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia. , 2004, Archives of internal medicine.
[49] Mitchell M. Levy,et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock , 2004, Critical care medicine.
[50] R. Prescott,et al. Does the storage time of transfused red blood cells influence regional or global indexes of tissue oxygenation in anemic critically ill patients?* , 2004, Critical care medicine.
[51] N. H. Steigbigel. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock , 2003, Current infectious disease reports.
[52] L. McCaig,et al. National Hospital Ambulatory Medical Care Survey: 2001 emergency department summary. , 2003, Advance data.
[53] Claude D Martin,et al. Empirical antimicrobial therapy of septic shock patients: Adequacy and impact on the outcome* , 2003, Critical care medicine.
[54] M. Astiz,et al. Impaired mitochondrial function induced by serum from septic shock patients is attenuated by inhibition of nitric oxide synthase and poly(ADP-ribose) synthase* , 2003, Critical care medicine.
[55] G. Chertow,et al. Diuretics, mortality, and nonrecovery of renal function in acute renal failure. , 2002, JAMA.
[56] Can Ince,et al. Nitroglycerin in septic shock after intravascular volume resuscitation , 2002, The Lancet.
[57] J. Vincent,et al. Anemia and blood transfusion in critically ill patients. , 2002, JAMA.
[58] William C. Shoemaker,et al. Meta-analysis of hemodynamic optimization in high-risk patients* , 2002, Critical care medicine.
[59] E. Ivers,et al. Early Goal-Directed Therapy in the Treatment of Severe Sepsis and Septic Shock , 2001 .
[60] Shigeaki Kobayashi,et al. Serial Measurement of Arterial Lactate Concentrations as a Prognostic Indicator in Relation to the Incidence of Disseminated Intravascular Coagulation in Patients with Systemic Inflammatory Response Syndrome , 2001, Surgery Today.
[61] J. Gogas,et al. Central Venous and Mixed Venous Oxygen Saturation in Critically Ill Patients , 2001, Respiration.
[62] J Ean,et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. , 2001, The New England journal of medicine.
[63] D. Pinsky,et al. The endothelial response to oxygen deprivation: biology and clinical implications , 2001, Intensive Care Medicine.
[64] Hollenberg. Top ten list in myocardial infarction , 2000, Chest.
[65] L. Worthley,et al. Digoxin in the critically ill patient. , 1999, Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine.
[66] N. Mann,et al. Population-based research assessing the effectiveness of trauma systems. , 1999, The Journal of trauma.
[67] J. Fischer,et al. Lactate is an unreliable indicator of tissue hypoxia in injury or sepsis , 1999, The Lancet.
[68] S. Opal,et al. Clinical trials for severe sepsis. Past failures, and future hopes. , 1999, Infectious disease clinics of North America.
[69] G. Wells,et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. , 1999, The New England journal of medicine.
[70] G Sherman,et al. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. , 1999, Chest.
[71] S. McJames,et al. Effects of dobutamine, norepinephrine and epinephrine on intramucosal pH and hemodynamics of dogs during endotoxic shock. , 1998, Acta anaesthesiologica Sinica.
[72] Edwards Jd,et al. Importance of the sampling site for measurement of mixed venous oxgen saturation in shock , 1998 .
[73] R. Wenzel,et al. Septic shock: an analysis of outcomes for patients with onset on hospital wards versus intensive care units. , 1998, Critical care medicine.
[74] D. Fuchs,et al. Erythropoietin response is blunted in critically ill patients. , 1997, Intensive care medicine.
[75] W. Jelkmann,et al. Serum erythropoietin levels in patients with sepsis and septic shock , 1996, European journal of haematology.
[76] M. Grzybowski,et al. Systemic inflammatory response syndrome criteria and lactic acidosis in the detection of critical illness among patients presenting to an emergency department , 1996 .
[77] R. Strieter,et al. Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome. , 1996, American journal of respiratory and critical care medicine.
[78] J. Younger,et al. Relationship between arterial and peripheral venous lactate levels. , 1996, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.
[79] R. Nowak,et al. Resuscitation of the critically ill in the ED: responses of blood pressure, heart rate, shock index, central venous oxygen saturation, and lactate. , 1996, The American journal of emergency medicine.
[80] P. Pelosi,et al. A Trial of Goal-Oriented Hemodynamic Therapy in Critically Ill Patients , 1995 .
[81] François Gouin,et al. Incidence, Risk Factors, and Outcome of Severe Sepsis and Septic Shock in Adults: A Multicenter Prospective Study in Intensive Care Units , 1995 .
[82] F Doyon,et al. Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. French ICU Group for Severe Sepsis. , 1995, JAMA.
[83] J. Vincent,et al. Oxygen uptake/oxygen supply dependency: Fact or fiction? , 1995, Acta anaesthesiologica Scandinavica. Supplementum.
[84] B. Chernow,et al. The use and clinical importance of a substrate-specific electrode for rapid determination of blood lactate concentrations. , 1994, JAMA.
[85] H. Smithline,et al. A comparison of the shock index and conventional vital signs to identify acute, critical illness in the emergency department. , 1994, Annals of emergency medicine.
[86] C. Hinds,et al. Elevation of systemic oxygen delivery in the treatment of critically ill patients. , 1994, The New England journal of medicine.
[87] F. Cerra,et al. Multiple organ failure syndrome in the 1990s. Systemic inflammatory response and organ dysfunction. , 1994, JAMA.
[88] W J Sibbald,et al. Effect of stored-blood transfusion on oxygen delivery in patients with sepsis. , 1993, JAMA.
[89] E. Rackow,et al. Mechanisms and management of septic shock. , 1993, Critical care clinics.
[90] M. Hiesmayr,et al. Mixed venous oxygen saturation in critically ill septic shock patients. The role of defined events. , 1993, Chest.
[91] J. Oropello,et al. Systemic hypoxic and inflammatory syndrome: An alternative designation for “sepsis syndrome” , 1992, Critical care medicine.
[92] E. Rackow,et al. Pathophysiology and treatment of septic shock. , 1991, JAMA.
[93] F. Ognibene,et al. Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. , 1990, Annals of internal medicine.
[94] J. Vincent,et al. Dobutamine administration in septic shock: addition to a standard protocol. , 1990, Critical care medicine.
[95] O. Nielsen,et al. Erythropoietin deficiency in acute tubular necrosis , 1990, Journal of internal medicine.
[96] S. Cain,et al. Comparison of central-venous to mixed-venous oxygen saturation during changes in oxygen supply/demand. , 1989, Chest.
[97] S. Nasraway,et al. Inotropic response to digoxin and dopamine in patients with severe sepsis, cardiac failure, and systemic hypoperfusion. , 1989, Chest.
[98] W. Shoemaker,et al. Prospective trial of supranormal values of survivors as therapeutic goals in high-risk surgical patients. , 1988, Chest.
[99] M. Weil,et al. Relationship of oxygen delivery and mixed venous oxygenation to lactic acidosis in patients with sepsis and acute myocardial infarction. , 1988, Critical care medicine.
[100] J. Shelhamer,et al. A circulating myocardial depressant substance in humans with septic shock. Septic shock patients with a reduced ejection fraction have a circulating factor that depresses in vitro myocardial cell performance. , 1985, The Journal of clinical investigation.
[101] J. Hassett,et al. Vasodilator therapy in clinical sepsis with low output syndrome. , 1978, The Journal of surgical research.
[102] Mokgokong Et. Treatment of septicaemic shock in gynaecology and obstetrics. , 1973 .
[103] L. Cady,et al. Quantization of severity of critical illness with special reference to blood lactate , 1973, Critical care medicine.
[104] E. Frank. A SHOCK TEAM IN A GENERAL HOSPITAL , 1967, Anesthesia and analgesia.
[105] M. Weil,et al. EXCESS LACTATE: AN INDEX OF REVERSIBILITY OF SHOCK IN HUMAN PATIENTS. , 1964, Science.
[106] Max H. Weil,et al. Excess Lactate: An Index of Reversibility of Shock in Human Patients , 1964, Science.
[107] S. Corbett,et al. Early goal-directed therapy, corticosteroid, and recombinant human activated protein C for the treatment of severe sepsis and septic shock in the emergency department. , 2006, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.
[108] G. Bernard,et al. Pulmonary-artery versus central venous catheter to guide treatment of acute lung injury. , 2006, The New England journal of medicine.
[109] Jay Steingrub,et al. Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death. , 2005 .
[110] M. Donnino,et al. Cryptic Septic Shock: A Sub-analysis of Early, Goal-Directed Therap , 2003 .
[111] R. Waldrop,et al. Critical care provided in an urban emergency department. , 1998, The American journal of emergency medicine.
[112] J. Edwards,et al. Importance of the sampling site for measurement of mixed venous oxygen saturation in shock. , 1998, Critical care medicine.
[113] J. Vincent,et al. Oxygen extraction in patients with sepsis and heart failure: another look at clinical studies. , 1994, Clinical intensive care : international journal of critical & coronary care medicine.
[114] M. Weil,et al. Oxygen delivery and utilization during rapidly fatal septic shock in rats. , 1986, Circulatory shock.
[115] P. Safar,et al. Emergency and critical care medicine: local implementation of national recommendations. , 1974, Clinical anesthesia.
[116] L. Greenfield,et al. Prevention and reversal of myocardial failure in endotoxin shock. , 1973, Surgery, gynecology & obstetrics.
[117] E. Mokgokong. Treatment of septicaemic shock in gynaecology and obstetrics. , 1973, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.